Drug Development

Clinical Trials Research and Development Covid-19 Vaccines Regulatory Compliance Cancer Treatments Efficacy Studies Weight Loss Medications FDA Approval Cancer Drugs Monoclonal Antibodies Research Funding ALS Treatment Regulatory Approval Mental Health Treatments Cancer Therapies Antiviral Drugs Cancer Medicines Antibiotics

10 ARTICLES

4w ago

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

The pharmaceutical giant posts 10% revenue growth, accelerates US manufacturing and R&D plans, and faces legal scrutiny in China over tax and data issues.

4 ARTICLES

last mo.

Merck in Advanced Talks to Acquire Springworks Therapeutics for $3.5 Billion

8 ARTICLES

2mo ago

AstraZeneca Announces $2.5 Billion Beijing R&D Hub to Bolster China Presence

3 ARTICLES

3mo ago

Bristol Myers Squibb Predicts 2025 Revenue Decline, Expands Cost-Cutting Measures

4 ARTICLES

5mo ago

ALS Drug Relyvrio Fails Key Clinical Trial, May Be Pulled from Market

Drug Development

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

Merck in Advanced Talks to Acquire Springworks Therapeutics for $3.5 Billion

AstraZeneca Announces $2.5 Billion Beijing R&D Hub to Bolster China Presence

Bristol Myers Squibb Predicts 2025 Revenue Decline, Expands Cost-Cutting Measures

GLP-1 Drugs Revolutionize Prescriptions and Broader Health Applications

AstraZeneca's China Executive Detained Amid Drug Import Investigation

AstraZeneca's China President Under Investigation by Authorities

Experts Urge Action Amid Rising Antibiotic Resistance Crisis

Pfizer Withdraws Sickle Cell Drug Oxbryta Over Safety Concerns

ALS Drug Relyvrio Fails Key Clinical Trial, May Be Pulled from Market